Kim Sablich - Mar 11, 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 08:06 PM
Previous filing
Mar 9, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Award $0 +6K $0.00 6K Mar 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +12K $0.00 12K Mar 11, 2022 Common Stock 12K $5.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022.
F2 The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date.